Can muscle loss predict chemotherapy timing in ovarian cancer?
NCT ID NCT05415527
First seen Feb 01, 2026 · Last updated Apr 25, 2026 · Updated 14 times
Summary
This study examines muscle loss (sarcopenia) in 25 women with advanced ovarian cancer who cannot have surgery right away. Researchers will check CT scans taken before chemotherapy to see how common muscle loss is. The goal is to learn if muscle loss affects how quickly patients can start treatment, helping doctors plan better care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Bergonié
Bordeaux, France
Conditions
Explore the condition pages connected to this study.